ZNF521 and hepatocellular carcinoma: The PI3K/AKT signaling pathway can eliminate the inhibitory effect of ZNF521 on HCC cells, which indicates that the tumor‐promoting effect of miR‐802 is mediated by the PI3K/AKT signaling pathway in HCC.24